Introduction
Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and potential systemic damage. Fibromyalgia (FM) is a separate chronic disorder defined by widespread musculoskeletal pain, fatigue, and sleep disturbances, but lacking the inflammatory markers typical of RA. When these conditions coexist, they present a significant diagnostic challenge. The subjective nature of FM pain can inflate RA disease activity scores, potentially leading to clinical overtreatment with immunosuppressants. This study investigates the clinical and psychological profiles of RA patients with concurrent FM in a real-world Chinese clinical setting.
Methods
A cross-sectional study was conducted at Peking University People’s Hospital, involving 202 RA inpatients between December 2018 and June 2019. Patients were classified for FM using the 1990 American College of Rheumatology (ACR) criteria.
The researchers employed several validated instruments:
- Disease Activity Score in 28 Joints (DAS-28): Measures RA activity using tender/swollen joint counts and inflammatory markers.
- Short Form-36 (SF-36) & Health Assessment Questionnaire (HAQ): Evaluates quality of life and functional disability.
- Hospital Anxiety and Depression Scale (HADS): Assesses psychological status.
- Fatigue Assessment Instrument (FAI): Quantifies multi-dimensional fatigue.
- Pollard’s Standard: A screening tool where FM is suspected if the number of tender joints minus the number of swollen joints is $\ge$ 7.
Results
Of the 202 patients, 42 (20.8%) met the criteria for concurrent FM.
- Disease Activity: The RA-FM group showed significantly higher DAS-28 scores (6.0 vs. 4.4, P=0.011).
- Joint Counts: While Tender Joint Counts (TJC) were markedly higher in the RA-FM group (16.5 vs. 4.5, P<0.001), Swollen Joint Counts (SJC) showed no significant difference between the groups.
- Inflammatory Markers: Objective markers such as Erythrocyte Sedimentation Rate (ESR) and C-reactive protein (CRP) levels were nearly identical between groups, indicating that the higher DAS-28 in RA-FM patients was driven by pain perception rather than increased systemic inflammation.
- Psychological and Functional Status: RA-FM patients reported significantly higher anxiety (10 vs. 4) and depression (12 vs. 6) scores. They also experienced more fatigue (88.1% vs. 50.6%) and lower quality of life (SF-36 scores: 28.6 vs. 58.2).
Discussion
The coexistence of FM in RA patients creates a "subjectivity trap." Because the DAS-28 score relies heavily on tender joint counts, the increased pain sensitivity of FM patients can lead to an overestimation of RA disease activity. This study confirms that while RA-FM patients appear to have more severe disease based on composite scores, their objective inflammatory markers do not reflect this.
The high prevalence of anxiety and depression in the RA-FM group suggests a psychological feedback loop where chronic pain and mental health issues exacerbate one another. This highlights the need for a holistic treatment approach that addresses both the inflammatory aspects of RA and the central pain processing issues of FM.
Pollard’s standard proved to be a highly sensitive (95.2%) screening tool, making it useful for identifying patients who require further FM evaluation, although its lower specificity (52.6%) means it cannot be used for definitive diagnosis.
Conclusion and Limitations
Concurrent FM significantly impacts the clinical presentation and quality of life of RA patients. Clinicians should consider the possibility of FM when RA patients fail to reach remission despite low inflammatory markers.
Limitations of this study include its single-center inpatient focus and the use of subjective fatigue measures. Future longitudinal research is needed to evaluate the effectiveness of non-pharmacological interventions, such as psychotherapy and exercise, in this specific patient population.
Summary updated